Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (64 ops.)
Latest filing published 03 Sept 2026 for Denali Therapeutics Inc., €56k. Read the official filing
Filing timeline
BuySaleAlexander O. Schuth
Insider track record
Disclosed buys
0
Disclosed sells
64
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Alexander O. Schuth: trading record in brief
Alexander O. Schuth, listed as senior executive, appears in our data through filings on Denali Therapeutics Inc. shares, published by SEC (Form 4). The record holds 94 filings, for trades running from 22 June 2018 to 1 September 2026.
Every open-market trade on record is a sale: 64 sales worth €5.6M. Other entries cover 9 share grants and 21 option exercises. So far in 2026, the count stands at no purchases and 3 sales.
Most recently, on 3 September 2026, the filings show an open-market sale worth €56k in Denali Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alexander O. Schuth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
2,768 shares@ US$23.44Common StockSEC:0001724311-26-000014:0
2,857 shares@ US$25.070.0018% mcap1.5% of flowCommon StockSEC:0001724311-26-000013:0
17,218 shares@ US$16.505.9% of flowCommon StockSEC:0001724311-26-000005:0
57,700 shares0Common StockSEC:0001724311-26-000001:0
2,937 shares@ US$13.580.9% of flowCommon StockSEC:0001724311-25-000011:0
12,255 shares@ US$20.224.1% of flowCommon StockSEC:0001714899-25-000050:0
54,180 shares0Common StockSEC:0001714899-25-000027:0
6,708 shares@ US$5.280.6% of flowCommon StockSEC:0001714899-24-000236:0
20,516 shares@ US$0.680.2% of flowCommon StockSEC:0001714899-24-000234:0
15,558 shares@ US$5.281.3% of flowCommon StockSEC:0001714899-24-000218:0
2,453 shares@ US$23.790.9% of flowCommon StockSEC:0001714899-24-000195:0
2,272 shares@ US$22.890.8% of flowCommon StockSEC:0001714899-24-000177:0
2,716 shares@ US$17.290.7% of flowCommon StockSEC:0001714899-24-000059:0
50,000 shares@ US$0.680.5% of flowCommon StockSEC:0001714899-24-000042:0
9,972 shares@ US$19.433.0% of flowCommon StockSEC:0001714899-24-000036:0
53,720 shares0Common StockSEC:0001714899-24-000010:0
2,522 shares@ US$23.170.9% of flowCommon StockSEC:0001714899-23-000137:0
2,478 shares@ US$22.590.9% of flowCommon StockSEC:0001714899-23-000134:0
2,772 shares@ US$23.671.0% of flowCommon StockSEC:0001714899-23-000124:0
2,853 shares@ US$24.181.1% of flowCommon StockSEC:0001714899-23-000121:0
10,000 shares@ US$5.280.8% of flowCommon StockSEC:0001714899-23-000109:0
10,000 shares@ US$5.280.8% of flowCommon StockSEC:0001714899-23-000076:0
5,102 shares@ US$5.280.4% of flowCommon StockSEC:0001714899-23-000055:0
25,000 shares@ US$0.680.3% of flowCommon StockSEC:0001714899-23-000030:0
1,521 shares@ US$30.890.7% of flowCommon StockSEC:0001714899-23-000020:0
25 of 46 declarations
